Literature DB >> 2999870

Polyneuropathy induced by cisplatin.

B W Ongerboer de Visser, G Tiessens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2999870     DOI： 10.1159/000411639

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  11 in total

1.  The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.

Authors:  A Hovestadt; M E van der Burg; H B Verbiest; W L van Putten; C J Vecht
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

2.  GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced peripheral neuropathy.

Authors:  Sou Katayanagi; Kenji Katsumata; Yasuharu Mori; Katsunori Narahara; Masatoshi Shigoka; Takaaki Matsudo; Masanori Enomoto; Takeshi Suda; Tetsuo Ishizaki; Masayuki Hisada; Yuuichi Nagakawa; Akihiko Tsuchida
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

3.  The flexor carpi radialis H-reflex in polyneuropathy: relations to conduction velocities of the median nerve and the soleus H-reflex latency.

Authors:  R J Schimsheimer; B W Ongerboer de Visser; B Kemp; L J Bour
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

4.  Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors:  W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

5.  Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Authors:  G Bogliun; L Marzorati; G Cavaletti; L Frattola
Journal:  Ital J Neurol Sci       Date:  1992-11

6.  Electric shock-like sensations in 42 cancer patients: clinical characteristics and distinct etiologies.

Authors:  A Lossos; T Siegal
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

7.  The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.

Authors:  J M van Gerven; A Hovestadt; J W Moll; C J Rodenburg; T A Splinter; A T van Oosterom; L Keizer; T E Drogendijk; C M Groenhout; C J Vecht
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

8.  Cisplatin neuropathy: clinical course and neurophysiological findings.

Authors:  M LoMonaco; M Milone; A P Batocchi; L Padua; D Restuccia; P Tonali
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

9.  Changes in laryngeal sensation evaluated with a new method before and after radiotherapy.

Authors:  Kikuko Ozawa; Yasushi Fujimoto; Tsutomu Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-25       Impact factor: 2.503

10.  Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.

Authors:  Min-Suk Yoon; Zaza Katsarava; Mark Obermann; Maria Schäfers; Bernd Liedert; Anna Dzagnidze; Andreas Kribben; Rupert Egensperger; Volker Limmroth; Hans-Christoph Diener; Juergen Thomale
Journal:  BMC Neurosci       Date:  2009-07-15       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.